In the early to mid 1980s, the WHO MONICA Project conproportion of participants with untreated major elevation of BP ranged from 4.5% to 33.7% in men and from ducted cardiovascular risk factor surveys in 41 study populations in 22 countries. Study populations aged 35-1.9% to 22.3% in women. The proportions of participants receiving antihypertensive medication were 4.3-17.7% 64 years comprised 32 422 men and 32 554 women. Blood pressures (BP) and body mass index (BMI) were for men and 6.0-22.0% for women. These proportions were not correlated with the prevalence of untreated measured according to a standard protocol. Participants were asked about antihypertensive medication.
Introduction
accepted, to the extent that professional guidelines Blood pressure (BP) profiles in populations have for the non-pharmacological treatment of hypertenbeen compared by many investigators. [1] [2] [3] [4] [5] [6] [7] [8] These sion recommend measures to reduce body weight as studies have made major contributions to hypertenan initial step. 11 One may therefore expect that difsion research by generating hypotheses about the ferences between population in means of BMI may mechanisms that cause elevated BP, such as the salt also account for some of the differences in means hypothesis.
9 BP can be affected by medical interof SBP. vention as well as environmental factors such as BP data from different populations sometimes are lifestyle and diet. The large changes in these factors difficult to interpret because few of the data have that are occurring in westernized as well as been collected using a common study design and the developing countries may provide new information number of populations involved may be small. For about factors that influence human BP. Such inforthese reasons, the WHO MONICA Project 12 provides mation may help to identify possible ways in which an attractive framework for the inter-population BP is influenced at the population level, either by study of BP. The WHO MONICA Project was antihypertensive medication or by non-pharmacoinitiated in the early 1980s as a collaborative effort logical means. BP in individuals has been shown in in 27 countries, involving 49 study populations, some studies to be significantly related to salt with the objective of monitoring trends and determiintake. 10 It has also been demonstrated that within nants of cardiovascular disease over a 10-year perpopulations the level of salt intake is associated iod. A uniform study protocol was adopted with at with the difference in BP between older and younger least two coronary disease risk factor surveys to be individuals, ie, the higher the salt intake the steeper conducted in each MONICA Study Population the BP rise with age. It is possible that some of the (MSP), the first of them close to the start of the study difference in BP between populations is also due to period. Although the MONICA Project was not a difference in salt consumption.
designed to compare risk factors between popu-A causal relationship between elevated body mass lations, such comparisons may be made if sufficient care is taken in the interpretation of the results. The
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interesting source for comparison of BP profiles are:
factor surveys were conducted in random samples individual, and an indication of a trend in measurements during the survey period. SSQ ranged from of the target populations and the sample sizes were large; (iii) the surveys have been performed more or zero for insufficient quality to two for data without quality problems. Of the 49 MSPs, eight were less concurrently; (iv) all data are subject to central quality assessment; and (v) the important elements excluded from the analyses for this paper; one because BP data were available for fewer than 40% of data collection were common for all MSPs.
We therefore analysed the data of the MONICA of people invited to participate in the survey, and seven for SSQ = 0. baseline surveys with the objective of establishing the extent of BP variations between the populations Hypertension treatment was determined by asking each survey participant: 'Are you taking (in the past and of exploring possible factors that might explain these differences. Specifically, we addressed the fol-2 weeks) drugs for high blood pressure?' Response rates for the survey were calculated in lowing questions: two ways, using different denominators. For some • What is the range of BP differences between popupopulations, the sampling frame was inaccurate and lations? migration was common. In such cases, subjects were • How does BP vary with age in different popusometimes selected for the sample that could not be lations?
contacted and their residence in the study area • What is the difference in the pattern of BP could not be verified. One response rate was calcubetween men and women in different populated regarding these people as non-respondents and lations?
hence including them in the denominator (Response • How do populations differ regarding prevalence of rate A in Table 1 ). For the association between BMI and SBP we Two BP measurements were made after at least 5 min of rest. In most MSPs the participants were in excluded three of the 41 MSPs because of an inadequate data quality for height and weight measurea sitting position, except one MSP recorded BP on supine subjects (BEL-LUX). In all but three MSPs ments. A different five were eliminated from the analyses involving hypertension treatment due to (BEL-LUX, HUN-PEC, ICE-ICE) the BP was consistently measured in the right arm. The average of the inadequate information on treatment. The age of survey participants was defined as the two BP measurements was used for analysis. Systolic BP (SBP) and diastolic BP (DBP) were defined age at their most recent birthday. Age standardized values were calculated by the direct method, using as phase I and phase V of the Korotkoff sounds respectively. No uniform standard applied to the the World Standard Population 16 with the weights 12/31, 11/31, and 8/31 applied for the age groups choice of BP cuff sizes. In 25 of 41 study populations one cuff size was used for all participants. [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] respectively . For calculation of the age gradient of BP, a linear regression populations, a selection was made from two or three different cuff sizes. For three MSPs, the number of model was fitted to the data of each MSP with SBP as the response and age in single years as the cuff sizes could not be determined. In 14 of the MSPs, a random zero sphygmomanometer was used; explanatory variable, using the REG procedure of SAS. 17 The crossover age was defined as the age 13 employed the Hawksley model 13 and one an electronic machine.
14 In the remaining 27 MSPs, BP was where the regression lines for men and women crossed one another. The associations between agerecorded with a standard mercury sphygmomanometer.
standardized values of SBP and BMI and between mean SBP and prevalence of high BP were also anaThe BP data collected by each MSP were subjected to central quality assessment, using an algorlysed with the SAS procedure REG. We defined the variables FTR and FHP in order ithm specifically developed for MONICA. 15 The data from each MSP received a summary score for the to assess differences between MSPs in the extent of treatment for hypertension. FTR is the age-stanquality (SSQ) of BP measurement. The SSQ incorporated the proportion of incomplete measuredardized fraction of participants who reported treatment for hypertension. FHP is the age-standardized ments, terminal digit preference, frequency of identical consecutive measurements in the same fraction of participants who did not receive treat- Populations printed in bold used a random-zero sphygmomanometer.
had population mean SBP levels 2.5 mm Hg higher small. In all MSPs the age gradient for women was greater than for men. In 34 of the MSPs the differthan those of women. Among men 12 of the 41 populations (27%) and among women nine of 41 ence in gradient was large enough to lead to a crossover of the regression lines for men and women. populations (22%) had mean SBP levels at or above 140 mm Hg, a level that many health professionals Figure 1A and 1B display the distribution of age gradient for SBP in men and women. They show that consider as a threshold for intervention in individuals. There was a close relationship (r 2 = 0.86 for the age gradients are all statistically significantly greater than zero. The gradients for women are larger men, r 2 = 0.77 for women) between means for SBP and the percentage of respondents with high BP than for men. In Figure 2 we show the association between BP age gradient and mean SBP. The slope (SBP у160 mm Hg or DBP у95 mm Hg). An increase in SBP by 1 mm Hg was associated with an increase of the regression line is significantly different from zero for women (P = 0.0004), but not for men (P = in prevalence of high BP by 1.45% and 1.27% in male and female populations respectively. 0.42).
Treatment of hypertension Blood pressure gradient with age
There were differences in the age gradient of BP In Table 4 we report for each MSP the percentage of men and women respectively who reported receivbetween the two sexes. Table 3 lists the age group specific SBP for men and women. In all MSPs ing antihypertensive medication (FTR) and those who were found to have an elevation of BP but not women had a lower mean SBP than men in the age group 35-44, although some of the differences were receiving treatment (FHP). There is a close relation- ship between FHP in men and FHP in women lations, and age group was used as a categorical variable. We found that, after adjusting for age group, (Spearman rank order correlation = 0.95). The correlation coefficient between FTR and FHP for men was BMI had a significant association with the population means of SBP and accounted for 14% of the r = 0.13 (P = 0.4) and for women r = 0.35 (P = 0.07). For both sexes, higher prevalence of treatment is not variance in men and 32% in women. associated with lower prevalence of untreated elevated BP. We also investigated whether higher mean
Discussion
BP of the population sample is associated with higher values of FTR. The correlation between SBP Blood pressure differences and FTR was r = 0.3 (P = 0.03) and r = 0.5 (P = 0.002) for men and women respectively.
In this paper we examined BP distributions in 41 MONICA populations. With the exception of Beijing, the study populations were all of Caucasian oriBlood pressure and body mass index gin, but covered a wide range of geo-political and socio-economic conditions. Figure 3 shows the relationship between age-standardized values of SBP and BMI. To test the hypothWe found large differences in BP between the study populations. The range of 24 mm Hg for mean esis that the population means of BMI account for some of the variation of SBP, we performed a SBP may appear small in comparison with BP differences that are found between individuals. However, regression analysis between BMI and SBP. The units of analysis were the 10-year age groups of the popuwe determined that even small shifts in mean popu- MSPs. This assumption is supported by the simi-GER-AUR 5.9 15.7 9.5 9.8 larity of our finding to those of the Intersalt study. lations from the results of the Intersalt study, then the SBP range in that study is almost identical to that for the MONICA data presented here. However, the levels of mean SBP in the MONICA Project were lation BP values translate into large changes of prevalence of hypertension. The range of 24 mm Hg, about 15 mm Hg higher, probably because the Intersalt population was aged 20-59, compared to therefore, carries major public health implications. To some extent, these BP differences can be the age range of 35-64 for MONICA. The MONICA MSPs differ not only in their mean explained by corresponding differences in BMI, since we detected a significant association between SBP but they also show quite diverse values for BP age gradients. Since age gradients in populations BMI and SBP across study populations. The association was particularly strong for women. Our values have been associated with level of salt consumption, the observed gradient diversity may reflect a differfor the SBP-BMI association are similar to those reported by the Intersalt Research Group. 6 ence in salt consumption between MSPs. However, this hypothesis cannot be tested since MONICA has The question whether the SBP differences are exaggerated by the difference in treatment of hypernot collected nutrition data. tension could only be qualitatively assessed. If the hypertension treatment is effective, one expects that Measurement quality considerations with increasing fraction of persons under treatment there will be a truncation of the BP distribution There were some methodological factors that could have influenced our findings. For example, some resulting in decreased mean SBP. Since we found a positive correlation between FTR and SBP, it folMSPs used random-zero sphygmomanometers, whereas others employed standard devices. It has lows that populations with high mean BPs will have their SBP values more decreased than populations been suggested that the random-zero machines give SBP measurements on average 1.6 to 1.7 mm Hg with low mean BPs. It can therefore be surmised that the pattern of hypertension treatment will tend to below the standard machines. 18, 19 
